|
LCLAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9533997469855E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0495000424271E-09 |
| Normal-vs-Stage2 |
3.926000E-02 |
| Normal-vs-Stage3 |
2.93653990013354E-12 |
| Normal-vs-Stage4 |
6.7264000003231E-07 |
| Stage1-vs-Stage2 |
1.976270E-02 |
| Stage1-vs-Stage3 |
9.320200E-02 |
| Stage1-vs-Stage4 |
5.017200E-01 |
| Stage2-vs-Stage3 |
2.224300E-03 |
| Stage2-vs-Stage4 |
1.760230E-02 |
| Stage3-vs-Stage4 |
6.985000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.86024545662167E-13 |
| Normal-vs-AfricanAmerican |
2.799800E-02 |
| Normal-vs-Asian |
3.25999999994941E-06 |
| Caucasian-vs-AfricanAmerican |
1.483750E-02 |
| Caucasian-vs-Asian |
4.418200E-01 |
| AfricanAmerican-vs-Asian |
1.397250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.68499999975947E-07 |
| Normal-vs-Female |
1.11429976357158E-10 |
| Male-vs-Female |
2.857800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72470004944358E-09 |
| Normal-vs-Age(41-60Yrs) |
1.02349995145801E-09 |
| Normal-vs-Age(61-80Yrs) |
3.87160000003828E-06 |
| Normal-vs-Age(81-100Yrs) |
1.102560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.158800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.083640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.089000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.221900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.893200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.642800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.5806499999993E-05 |
| Classical-VS-Follicular |
5.29539999960527E-07 |
| Classical-VS-Other |
2.887000E-01 |
| Classical-VS-Normal |
1.13860032513458E-11 |
| Tall-VS-Follicular |
1.0564882302333E-12 |
| Tall-VS-Other |
5.290000E-01 |
| Tall-VS-Normal |
3.26405569239796E-14 |
| Follicular-VS-Other |
1.411770E-02 |
| Follicular-VS-Normal |
9.233700E-02 |
| Other-VS-Normal |
7.244700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.38429999996248E-06 |
| Normal-vs-N1 |
3.18745030369882E-12 |
| N0-vs-N1 |
1.71472999999089E-05 |
|
|
